{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:04:35Z","timestamp":1790229875503,"version":"4.1.0"},"reference-count":117,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Chronic inducible urticaria (CIndU) affects approximately 0.5% of the population and is characterized by wheals triggered by specific stimuli, such as cold or heat exposure, physical exertion, mechanical friction, vibration, or delayed pressure, distinguishing it from chronic spontaneous urticaria. Biomarkers may improve diagnosis, define endotypes, predict disease course, monitor treatment responses, and subsequently guide personalized treatment strategies. This scoping review aimed to map current evidence on diagnostic, prognostic, predictive, and monitoring or treatment-response biomarkers in CIndU, with a focus on H1-antihistamine and omalizumab therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This scoping review was conducted according to the Joanna Briggs Institute methodology and reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping reviews guidelines. Embase, MEDLINE, and Web of Science were searched from inception to January 29, 2026. Screening and data extraction were performed independently by two reviewers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Out of 3394 screened studies, 42 studies were included, revealing a heterogeneous and exploratory evidence base with limited validation across biomarkers and CIndU subtypes. No diagnostic biomarkers were identified for several subtypes, including cold, delayed pressure, and solar urticaria. In cholinergic urticaria, sweat-related immunoglobulin E (IgE) showed moderate diagnostic potential for a sweat allergy endotype but requires validation. In symptomatic dermographism, exploratory omics-based approaches identified molecular alterations but lack clinical applicability. Across CIndU subtypes, prognostic biomarkers showed exploratory associations with disease duration and severity. In cold urticaria, provocation-based parameters were associated with disease severity and response to H1-antihistamines, while total IgE showed exploratory potential for predicting omalizumab response. Routine laboratory markers were generally not reliable for treatment response or disease monitoring in CIndU.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Several promising exploratory biomarkers have been identified across CIndU subtypes, providing a foundation for future research. Integrative multi-omics approaches, such as those being applied in the SKINERGY CIndU pilot study within the Next Generation ImmunoDermatology consortium, hold promise for advancing biomarker discovery. External validation in large, well-characterized cohorts through international networks, such as Urticaria Centers of Reference and Excellence (UCARE), will be pivotal for clinical translation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1909765","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:43:49Z","timestamp":1790228629000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Scoping review: biomarkers in chronic inducible urticaria"],"prefix":"10.3389","volume":"17","author":[{"given":"Fauve R.","family":"van den Berge","sequence":"first","affiliation":[{"name":"Department of Dermatology, Erasmus MC, University Medical Center Rotterdam","place":["Rotterdam, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette V. L.","family":"Simons","sequence":"additional","affiliation":[{"name":"Department of Dermatology\/Allergology, University Medical Centre Utrecht, Utrecht University","place":["Utrecht, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"R\u00f6ckmann","sequence":"additional","affiliation":[{"name":"Department of Dermatology\/Allergology, University Medical Centre Utrecht, Utrecht University","place":["Utrecht, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn B. A.","family":"van Doorn","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Erasmus MC, University Medical Center Rotterdam","place":["Rotterdam, Netherlands"]},{"name":"Centre for Human Drug Research","place":["Leiden, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1111\/all.70210","article-title":"The international guideline for the definition, classification, diagnosis and management of urticaria","volume":"81","author":"Zuberbier","year":"2026","journal-title":"Allergy"},{"key":"B2","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jaad.2018.01.020","article-title":"Urticaria: a comprehensive review: epidemiology, diagnosis, and work-up","volume":"79","author":"Antia","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1016\/j.jaip.2025.07.019","article-title":"Subtypes of atypical cold urticaria and recommendations for their diagnostic workup","volume":"13","author":"Ahsan","year":"2025","journal-title":"J Allergy Clin Immunology: In Pract"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1542\/peds.113.4.e313","article-title":"Clinical features and anaphylaxis in children with cold urticaria","volume":"113","author":"Alangari","year":"2004","journal-title":"Pediatrics"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2024.07.008","article-title":"Skin reaction patterns in cholinergic urticaria","volume":"74","author":"Shurmelova","year":"2025","journal-title":"Allergology Int"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-025-00967-3","article-title":"Use of the rash appearance to distinguish cholinergic urticaria subtypes: a retrospective cohort study","volume":"26","author":"Nagai","year":"2025","journal-title":"Am J Clin Dermatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s40257-022-00728-6","article-title":"Cholinergic urticaria: subtype classification and clinical approach","volume":"24","author":"Fukunaga","year":"2023","journal-title":"Am J Clin Dermatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19561","article-title":"The global burden of chronic urticaria for the patient and society","volume":"184","author":"Gon\u00e7alo","year":"2021","journal-title":"Br J Dermatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12661","article-title":"Symptomatic dermographism: an inadequately described disease","volume":"29","author":"Schoepke","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2017.02.283","article-title":"Management of chronic inducible urticaria according to the guidelines: a prospective controlled study","volume":"87","author":"Kocat\u00fcrk","year":"2017","journal-title":"J Dermatol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.13979","article-title":"Real-life treatment of patients with cholinergic urticaria in German-speaking countries","volume":"17","author":"Mellerowicz","year":"2019","journal-title":"J Dtsch Dermatol Ges"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2024.2056","article-title":"Multinational drug survival study of omalizumab in patients with chronic urticaria and potential predictors for discontinuation","volume":"160","author":"Soegiharto","year":"2024","journal-title":"JAMA Dermatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/all.16334","article-title":"Omalizumab is effective and safe in chronic inducible urticaria (CIndU): real-world data from a large multi-national UCARE study","volume":"80","author":"Soegiharto","year":"2025","journal-title":"Allergy"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/all.13949","article-title":"Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: results of the PURIST study","volume":"74","author":"Schoepke","year":"2019","journal-title":"Allergy"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1016\/j.jaip.2023.05.033","article-title":"Association between serum total IgE levels and clinical response to omalizumab for chronic spontaneous urticaria: a systematic review and meta-analysis","volume":"11","author":"Chuang","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.04.010","article-title":"Autoimmune chronic spontaneous urticaria","volume":"149","author":"Kolkhir","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2013.06.005","article-title":"The faces of personalized medicine: a framework for understanding its meaning and scope","volume":"16","author":"Redekop","year":"2013","journal-title":"Value Health"},{"key":"B18","volume-title":"Integraal Zorgakkoord: \u201cSamen werken aan gezonde zorg\u201d","year":"2022"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1002629","article-title":"ImmUniverse Consortium: multi-omics integrative approach in personalized medicine for immune-mediated inflammatory diseases","volume":"13","author":"Vetrano","year":"2022","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00748-w","article-title":"HIPPOCRATES: improving diagnosis and outcomes in psoriatic arthritis","volume":"18","author":"FitzGerald","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1111\/jdv.7031","article-title":"Multi\u2010omics profiling of chronic immune\u2010mediated skin diseases: SKINERGY protocol and strategic evaluation","volume":"40","author":"Koster","year":"2026","journal-title":"J Eur Acad Dermatol Venereology"},{"key":"B22","volume-title":"BEST (Biomarkers, EndpointS, and other Tools) Resource","year":"2016"},{"key":"B23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"B24","unstructured":"JBI Manual for Evidence Synthesis\n          \n          \n            \n              Aromataris\n              E\n            \n            \n              Lockwood\n              C\n            \n            \n              Porritt\n              K\n            \n            \n              Pilla\n              B\n            \n            \n              Jordan\n              Z\n            \n          \n          JBI\n          \n          2024"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1558284","article-title":"Cold-induced anaphylaxis: new insights into clinical and genetic characteristics","volume":"16","author":"Bizjak","year":"2025","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e13751","DOI":"10.1111\/pai.13751","article-title":"Cold urticaria in a pediatric cohort: clinical characteristics, management, and natural history","volume":"33","author":"Prosty","year":"2022","journal-title":"Pediatr Allergy Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(94)90360-3","article-title":"Tumor necrosis factor-alpha release during systemic reaction in cold urticaria","volume":"93","author":"Tillie-Leblond","year":"1994","journal-title":"J Allergy Clin Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1159\/000536579","article-title":"Unveiling treatment response predictors in predominant subtypes of chronic inducible urticaria","volume":"185","author":"Ornek Ozdemir","year":"2024","journal-title":"Int Arch Allergy Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19425","article-title":"Omalizumab for the treatment of chronic inducible urticaria in 80 patients","volume":"184","author":"Exposito-Serrano","year":"2021","journal-title":"Br J Dermatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/clt2.12117","article-title":"IgE and high-affinity IgE receptor in chronic inducible urticaria, pathogenic, and management relevance","volume":"12","author":"Gimenez-Arnau","year":"2022","journal-title":"Clin Transl Allergy"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/all.12171","article-title":"Up-dosing with bilastine results in improved effectiveness in cold contact urticaria","volume":"68","author":"Krause","year":"2013","journal-title":"Allergy"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1983.tb01152.x","article-title":"Acquired cold urticaria: H1 and H2 antagonists versus cold induced histamine release","volume":"10","author":"Katayama","year":"1983","journal-title":"J Dermatol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(88)90968-2","article-title":"Prostaglandin D2 and histamine release in cold urticaria unaccompanied by evidence of platelet activation","volume":"82","author":"Ormerod","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.2002.23893_3.x","article-title":"Histamine release in idiopathic cold urticaria","volume":"57","author":"Asero","year":"2002","journal-title":"Allergy"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(80)90161-x","article-title":"The role of cyproheptadine in the treatment of cold urticaria","volume":"65","author":"Sigler","year":"1980","journal-title":"J Allergy Clin Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.665491","article-title":"Cold agglutinins and cryoglobulins associate with clinical and laboratory parameters of cold urticaria","volume":"12","author":"Bizjak","year":"2021","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1365-2133.2009.09441.x","article-title":"Results and relevance of critical temperature threshold testing in patients with acquired cold urticaria","volume":"162","author":"Mlynek","year":"2010","journal-title":"Br J Dermatol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.01.030","article-title":"H1-antihistamine inhibition of histamine- and codeine-induced wheals does not predict response in chronic cold urticaria","volume":"7","author":"Gorczyza","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1918","article-title":"Temperature thresholds in assessment of the clinical course of acquired cold contact urticaria: a prospective observational one-year study","volume":"95","author":"Martinez-Escala","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"B41","article-title":"A comparison of new nonsedating and classical antihistamines in the treatment of primary acquired cold urticaria (ACU)","volume":"2","author":"Villas Martinez","year":"1992","journal-title":"J Investig Allergol Clin Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2340\/00015555-0185","article-title":"Histamine, but not leukotriene C4, is an essential mediator in cold urticaria wheals","volume":"87","author":"Nuutinen","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-012-1236-2","article-title":"Histamine release-neutralization assay for sera of patients with atopic dermatitis and\/or cholinergic urticaria is useful to screen type I hypersensitivity against sweat antigens","volume":"304","author":"Shindo","year":"2012","journal-title":"Arch Dermatol Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2024.11.004","article-title":"Detection of anti-MGL_1304 IgE using the ImmunoCAP system for diagnosis of type I allergy to sweat","volume":"74","author":"Takahagi","year":"2025","journal-title":"Allergol Intern"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.955161","article-title":"Impaired sweating in patients with cholinergic urticaria is linked to low expression of acetylcholine receptor CHRM3 and acetylcholine esterase in sweat glands","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.12932\/ap-110625-2092","article-title":"Diagnostic performance and methodological concordance of the autologous sweat skin test for sweat allergy in a tropical setting: a pilot cross-sectional study","volume":"43","author":"Paringkarn","year":"2025","journal-title":"Asian Pac J Allergy Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2021.05.001","article-title":"Acetylcholine-induced whealing in cholinergic urticaria \u2013 what does it tell us","volume":"103","author":"Altrichter","year":"2021","journal-title":"J Dermatol Sci"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12549","article-title":"The significance of hypersensitivity to autologous sweat and serum in cholinergic urticaria: cholinergic urticaria may have different subtypes","volume":"54","author":"Kim","year":"2015","journal-title":"Int J Dermatol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.jaci.2018.08.050","article-title":"Real-life treatment of cholinergic urticaria with omalizumab","volume":"143","author":"Altrichter","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14010","article-title":"Omalizumab for cholinergic urticaria: 6 months prospective study and systematic review of the literature","volume":"33","author":"Ghazanfar","year":"2020","journal-title":"Dermatol Ther"},{"key":"B51","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13601-020-00324-z","article-title":"Sensitization against skin resident fungi is associated with atopy in cholinergic urticaria patients","volume":"10","author":"Altrichter","year":"2020","journal-title":"Clin Transl Allergy"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108636","article-title":"miR-126-3p and miR-16-5p as novel serum biomarkers for disease activity and treatment response in symptomatic dermographism","volume":"222","author":"Gao","year":"2021","journal-title":"Clin Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.933312","article-title":"Integrative lipidomic features identify plasma lipid signatures in chronic urticaria","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2024.01.032","article-title":"Identification of pyruvic and maleic acid as potential markers for disease activity and prognosis in chronic urticaria","volume":"154","author":"Jian","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14326","article-title":"Identification of gut microbiota signatures in symptomatic dermographism","volume":"30","author":"Liu","year":"2021","journal-title":"Exp Dermatol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2010.03699.x","article-title":"Analysis of plasma D-dimer concentration in patients with delayed pressure urticaria","volume":"25","author":"Kasperska-Zajac","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1159\/000524887","article-title":"Delayed pressure urticaria: clinical and diagnostic features and response to omalizumab","volume":"183","author":"Veleiro-Perez","year":"2022","journal-title":"Int Arch Allergy Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(91)70163-v","article-title":"Therapeutic effects of cetirizine in delayed pressure urticaria: clinicopathologic findings","volume":"24","author":"Kontou-Fili","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"B59","first-page":"520","article-title":"Cetirizine inhibits delayed pressure urticaria. Part 2. Skin biopsy findings","volume":"65","author":"Kontou-Fili","year":"1990","journal-title":"Ann Allergy"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v104.25576","article-title":"Solar urticaria: an ambispective study in a long-term follow-up cohort with emphasis on therapeutic predictors and outcomes","volume":"104","author":"Pesque","year":"2024","journal-title":"Acta Derm Venereol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2023.04.044","article-title":"Solar urticaria and omalizumab: A retrospective case\u2013control study and follow-up","volume":"115","author":"Casanova-Esquembre","year":"2024","journal-title":"Actas Dermo-Sifiliogr"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1111\/phpp.12370","article-title":"Clinical and photobiological response in eight patients with solar urticaria under treatment with omalizumab, and review of the literature","volume":"34","author":"Morgado-Carrasco","year":"2018","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1016\/j.jaip.2020.04.042","article-title":"Establishment of the basophil activation test to detect photoallergens in solar urticaria","volume":"8","author":"Oda","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1984.tb04639.x","article-title":"Studies on the mechanism of clinical tolerance in solar urticaria","volume":"110","author":"Keahey","year":"1984","journal-title":"Br J Dermatol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.134.1.71","article-title":"Solar urticaria. A report of 25 cases and difficulties in phototesting","volume":"134","author":"Ryckaert","year":"1998","journal-title":"Arch Dermatol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1053\/ac.2000.6347","article-title":"Solar urticaria: a report on 57 cases","volume":"11","author":"Monfrecola","year":"2000","journal-title":"Am J Contact Dermat"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03238.x","article-title":"The clinical and photobiological characteristics of solar urticaria in 40 patients","volume":"142","author":"Uetsu","year":"2000","journal-title":"Br J Dermatol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.23822\/EurAnnACI.1764-1489.343","article-title":"Salt dependent aquagenic urticaria: Nine new cases and proposal for a diagnostic work-up","volume":"56","author":"Gallo","year":"2024","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500611","article-title":"Vibratory urticaria associated with a missense variant in ADGRE2","volume":"374","author":"Boyden","year":"2016","journal-title":"N Engl J Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.jaci.2018.10.049","article-title":"Ordinary vibratory angioedema is not generally associated with ADGRE2 mutation","volume":"143","author":"Zhao","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"206","DOI":"10.4168\/AAIR.2021.13.2.206","article-title":"Total ige as a marker for chronic spontaneous urticaria","volume":"13","author":"Altrichter","year":"2021","journal-title":"Allergy Asthma Immunol Res"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2026.05.002","article-title":"Endotypes in chronic spontaneous urticaria","author":"Kaplan","year":"2026","journal-title":"J Allergy Clin Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/ced.12413","article-title":"Severity of acute and chronic urticaria correlates with D-dimer level, but not C-reactive protein or total IgE","volume":"39","author":"Baek","year":"2014","journal-title":"Clin Exp Dermatol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1159\/000314370","article-title":"Elevated serum total IgE - A potential marker for severe chronic urticaria","volume":"153","author":"Kessel","year":"2010","journal-title":"Int Arch Allergy Immunol"},{"key":"B75","first-page":"4434","article-title":"Pathogenic role of circulating CD4 + CXCR5 + cell subpopulations in patients with chronic spontaneous urticarial","volume":"12","author":"Gao","year":"2020","journal-title":"Am J Transl Res"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/0923-1811(94)90088-4","article-title":"Demonstration of sweat allergy in cholinergic urticaria","volume":"7","author":"Adachi","year":"1994","journal-title":"J Dermatol Sci"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08862.x","article-title":"Sweat antigen induces histamine release from basophils of patients with cholinergic urticaria associated with atopic diathesis","volume":"160","author":"Takahagi","year":"2009","journal-title":"Br J Dermatol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jaci.2005.05.024","article-title":"Responsiveness to autologous sweat and serum in cholinergic urticaria classifies its clinical subtypes","volume":"116","author":"Fukunaga","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2019.09.003","article-title":"Clinical utility of the basophil activation test in the diagnosis of sweat allergy","volume":"69","author":"Oda","year":"2020","journal-title":"Allergol Intern"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13390","article-title":"Serum carcinoembryonic antigen (CEA) as a clinical marker in acquired idiopathic generalized anhidrosis: a close correlation between serum CEA level and disease activity","volume":"30","author":"Honma","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.244","article-title":"Decreased expression of acetylcholine esterase in cholinergic urticaria with hypohidrosis or anhidrosis","volume":"134","author":"Sawada","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.188","article-title":"Cholinergic urticaria: studies on the muscarinic cholinergic receptor M3 in anhidrotic and hypohidrotic skin","volume":"130","author":"Sawada","year":"2010","journal-title":"J Invest Dermatol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3149","article-title":"Serum miR-125a-5p and CCL17 upregulated in chronic spontaneous urticaria and correlated with treatment response","volume":"99","author":"Zhang","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2008.07.002","article-title":"The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis","volume":"15","author":"Wang","year":"2008","journal-title":"Dev Cell"},{"key":"B85","doi-asserted-by":"publisher","first-page":"108583","DOI":"10.1016\/j.biopha.2019.01.044","article-title":"The role of microRNA-16 in the pathogenesis of autoimmune diseases: A comprehensive review","volume":"112","author":"Yan","year":"2019","journal-title":"Biomedicine Pharmacotherapy"},{"key":"B86","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.3390\/biomedicines13082014","article-title":"Beyond the skin: exploring the gut-skin axis in chronic spontaneous urticaria and other inflammatory skin diseases","volume":"13","author":"Haidar","year":"2025","journal-title":"Biomedicines"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.703126","article-title":"Biomarkers of gut microbiota in chronic spontaneous urticaria and symptomatic dermographism","volume":"11","author":"Liu","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1111\/exd.70261","article-title":"Unravelling the gut-skin axis in chronic urticaria: dysbiosis, metabolites and immunological mechanisms","volume":"35","author":"Wu","year":"2026","journal-title":"Exp Dermatol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1159\/000547368","article-title":"Probing the code of chronic urticaria pathogenesis: how the ceRNA network regulates mast cell activation","volume":"187","author":"He","year":"2026","journal-title":"Int Arch Allergy Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1007\/s40521-024-00366-9","article-title":"Risk of anaphylaxis associated with cold urticaria","volume":"11","author":"Bizjak","year":"2024","journal-title":"Curr Treat Options Allergy"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1111\/all.15194","article-title":"Risk factors for systemic reactions in typical cold urticaria: Results from the COLD-CE study","volume":"77","author":"Bizjak","year":"2022","journal-title":"Allergy: Eur J Allergy Clin Immunol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.iac.2006.05.010","article-title":"Diagnostic value of tryptase in anaphylaxis and mastocytosis","volume":"26","author":"Schwartz","year":"2006","journal-title":"Immunol Allergy Clinics North America"},{"key":"B93","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: Consensus statements on diagnostics, treatment recommendations and response criteria","volume":"37","author":"Valent","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"B94","doi-asserted-by":"publisher","first-page":"354","DOI":"10.2340\/00015555-1486","article-title":"The utility of serum tryptase as a marker in chronic spontaneous urticaria","volume":"93","author":"Siles","year":"2013","journal-title":"Acta Dermato-Venereologica"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/s0091-6749(99)70506-3","article-title":"Upregulation of TNF-alpha and IL-3 expression in lesional and uninvolved skin in different types of urticaria","volume":"103","author":"Hermes","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.07.055","article-title":"Elevated serum cytokines during human anaphylaxis: Identification of potential mediators of acute allergic reactions","volume":"124","author":"Stone","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"8853778","DOI":"10.1155\/drp\/8853778","article-title":"Chronic spontaneous urticaria severity relating to TNF-alpha serum concentration","volume":"2025","author":"Le","year":"2025","journal-title":"Dermatol Res Pract"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1980.tb15835.x","article-title":"Protease inhibitor profiles in urticaria and angio-oedema","volume":"103","author":"Eftekhari","year":"1980","journal-title":"Br J Dermatol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1975.01630200039001","article-title":"Protease inhibitors in plasma of patients with chronic urticaria","volume":"111","author":"Doeglas","year":"1975","journal-title":"Arch Dermatol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2016.37.4010","article-title":"Clinical and etiologic evaluation of the children with chronic urticaria","volume":"37","author":"Azkur","year":"2016","journal-title":"Allergy Asthma Proc"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.4168\/aair.2019.11.4.538","article-title":"Cold urticaria: Clinical features and natural course in a tropical country","volume":"11","author":"Kulthanan","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.25259\/ijdvl_727_2023","article-title":"Cold urticaria in tropics: A clinico-epidemiological study from North India","volume":"91","author":"Mehta","year":"2025","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1986.tb02822.x","article-title":"Cold urticaria and virus infections: a clinical and serological study in 39 patients","volume":"114","author":"Doeglas","year":"1986","journal-title":"Br J Dermatol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(78)90113-6","article-title":"Assessment of tissue fluid histamine levels in patients with urticaria","volume":"61","author":"Kaplan","year":"1978","journal-title":"J Allergy Clin Immunol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.675451","article-title":"Cryoglobulins, cryofibrinogens, and cold agglutinins in cold urticaria: Literature review, retrospective patient analysis, and observational study in 49 patients","volume":"12","author":"Ginter","year":"2021","journal-title":"Front Immunol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1992.tb02073.x","article-title":"Cold urticaria as a model of mediator release: platelet factor 4, eosinophil cationic protein and histamine","volume":"47","author":"Rosenkranz","year":"1992","journal-title":"Allergy"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(84)90258-6","article-title":"Release of platelet factor 4 into the blood after cold challenge of patients with cold urticaria","volume":"74","author":"Wasserman","year":"1984","journal-title":"J Allergy Clin Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1989.tb02601.x","article-title":"A timed study of the histopathology, direct immunofluorescence and ultrastructural findings in idiopathic cold-contact urticaria over a 24-h period","volume":"14","author":"Lawlor","year":"1989","journal-title":"Clin Exp Dermatol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(86)90033-3","article-title":"Prostaglandin D2 and histamine release in cold urticaria","volume":"78","author":"Heavey","year":"1986","journal-title":"J Allergy Clin Immunol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.2340\/0001555558369371","article-title":"Delayed cold urticaria","volume":"58","author":"Back","year":"1978","journal-title":"Acta Derm Venereol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19637","article-title":"A comparative analysis of chronic inducible urticaria in 423 patients: Clinical and laboratory features and comorbid conditions","volume":"38","author":"Ornek Ozdemir","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B112","article-title":"Cinnarizine is a useful and well-tolerated drug in the treatment of acquired cold urticaria (ACU)","volume":"13","author":"Tosoni","year":"2003","journal-title":"Eur J Dermatol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/bf00412493","article-title":"Immunofluorescent and histologic study of cold urticaria","volume":"278","author":"Winkelmann","year":"1985","journal-title":"Arch Dermatol Res"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2010.03951.x","article-title":"Physical urticaria: Prevalence, type and natural course in a tropical country","volume":"25","author":"Silpa-Archa","year":"2011","journal-title":"J Eur Acad Dermatol Venereology"},{"key":"B115","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13223-018-0310-5","article-title":"Review of cold-induced urticaria characteristics, diagnosis and management in a Western Canadian allergy practice","volume":"14","author":"Stepaniuk","year":"2018","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B116","first-page":"29","article-title":"Cold urticaria in Thai children: comparison between cyproheptadine and ketotifen in the treatment","volume":"13","author":"Visitsunthorn","year":"1995","journal-title":"Asian Pac J Allergy Immunol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12739","article-title":"An improved Peltier effect-based instrument for critical temperature threshold measurement in cold- and heat-induced urticaria","volume":"29","author":"Magerl","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1909765\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:43:53Z","timestamp":1790228633000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1909765\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":117,"alternative-id":["10.3389\/fimmu.2026.1909765"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1909765","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"article-number":"1909765"}}